Over the years, Unilab fueled its growth and shaped its development by increasing its capability to offer a wide range of high quality and affordable healthcare products. Underneath this drive for continuing market leadership is a profound and broad understanding of its social role, an understanding that underlies Unilab's commitment to a more meaningful and holistic corporate social responsibility.

From the very beginning, Unilab's history as a business organization is distinguished by a conscious and serious effort to strike a balance between the profit objective of business and the social objective of improving the health of as many people as possible in the markets where it is present. As a company, Unilab has undergone several changes - some fundamental, others strategic and operational - but this social mission has remained unchanged. It has been an enduring constant. Yet Unilab also understands that health is not merely the absence of sickness, but the optimum well-being of people to include physical, emotional, psychological and social aspects. Unilab thus undertakes deliberate steps towards this holistic objective, forging partnerships with numerous organizations where necessary, believing that progress is collaborative, its efforts sustainable and its impact developmental.

Guided by this philosophy first expressed by its founders, Unilab, in its own ways and with its available resources, continues to stay true to its social calling. Whether through its product donation program, community development initiatives, employee volunteerism activities or Pharmacoeconomics approach, Unilab remains steadfast in its efforts towards creating a difference where it truly matters.

Others call this corporate philanthropy. We at Unilab call it Bayanihan: our commitment beyond business.

The company launched Afford-a-Med in 2000, a price-reduction program that lowered the prices of several of its frequently prescribed drugs by 10 to 40 percent. The program covered 65 products considered as essential drugs commonly prescribed by doctors

UNILAB keeps refining its initiatives in lowering the prices of its medicine. In 2002, it launched a new division, RiteMed, which promises to deliver "right medicine, priced right." RiteMed manufactures and markets off-patent pharmaceuticals that are priced 20 to 80 percent lower than equivalent branded drugs.
The experience of the company arising out of its significant participation in the relief program in Central Luzon in the wake of super typhoon Yoling led it to set up the Bayanihan Agad Program. It incorporates the virtues of damayan and pagmamalasakit. The program operates on a concept of readiness to respond quickly to any calamity that may strike any part of the country. UNILAB fieldmen organize health teams to look after the medical needs of the victims and truckloads of medicines are rushed to evacuation centers.

UNILAB has also been tapping the services of Tahanang Walang Hagdan since 1964 for contract packaging of professional samples of its products. Tahanang Walang Hagdan is a community of the physically challenged. On the average, 30 members are fully employed in this project.

Back to top
Pharmacoeconomics, also known as health economics, is a form of rational drug therapy and disease management, taking into consideration the economic factors affecting the prescribing and purchasing decisions and the customers' allocation of healthcare practitioners about this topic. This serves as an eye-opener on the social relevance of the medical professionals' roles in the delivery of optimum healthcare benefits to patients given the current economic conditions.

Biomedis, a marketing division of UNILAB, unveiled its advocacy to "treat with the heart as well as the mind" through the Joy of Caring last 2002. The program aims to promote a unique partnership between the doctor and his patient, where technology is just a means and not an end, the doctor is an ally and not a king, and the patient is a partner and not a ward.

Back to top
UNILAB becomes the pioneer private company to support the Department of Health's campaign to eradicate tuberculosis in the country by providing resources to the Directly Observed Treatment Short Course (DOTS) program. A UNILAB-DOTS clinic was established in 1999 to extend medical service to TB patients in Pasig and Mandaluyong. The program's underlying objective is to ensure complete drug intake compliance of the patient and guarantee his or her full recovery. This is accomplished through rigid monitoring-a patient's failure to visit the doctor at the appointed time triggers a home call by program personnel.

UNILAB has also joined the Department of Health (DOH) and the Philippine College of Surgeons (PCS) in a five-year program to improve the delivery of surgical services in underserved provinces in the country. The program calls for intensive residency training in general surgery of government physicians in institutions accredited by the PCS and their eventual deployment in various government hospitals. UNILAB provides logistics support through the Professional Relations Management Division (PRMD).

United Laboratories In-Patient Assistance Program (UNIPAP) provides free UNILAB medicines for patients confined in the charity wards of government hospitals. The project was initiated in response to the problem being experienced by the medical center due to budget cuts and a direction from the national government for medical centers to operate autonomously.

Back to top
UNILAB collaborated with the UP Open University for UNILAB Mobile Technology Program, a unique and first-ever project to be undertaken in the country. The Mobile Technology Program aims to promote the development of science and technology in the country by stimulating the interest of bright high school students, bringing the concept of biotechnology and disseminating accurate information to raise the public's awareness on this field. To date, the program has visited 88 high schools all over Metro Manila.

Back to top
 
“Gotong Royong” is the Indonesian equivalent of Bayanihan. “Samankee” is the Thai equivalent.
News December 4, 2008
     
 
contact us email to friend view legal disclaimer